Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

NCT00702481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Nimotuzumab
DRUG: Cisplatin
RADIATION: Radiation

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]